CYBA p.Arg32His
c.95G>A · rs368862873 · VCV1001140
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0859 | likely benign |
|---|---|---|
| REVEL | 0.277 | benign-leaning |
| SaProt | LLR -5.57 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.38 | GERP -2.4, phastCons 0.2 |
| Regional constraint | o/e 1.20 | unconstrained · MANE · 7,657 bp · p 0.00077 · regional, not allelic |
| Overall | ||
| CADD | 17.82 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0111% | 8,971 |
| African / African-American | 0.004% | 24,981 |
| Admixed American | 0.00167% | 59,942 |
| European (non-Finnish) | 0.000763% | 131,093 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CYBA
- Protein
- p.Arg32His
- Coding
- c.95G>A
- MANE Select
- NM_000101
- dbSNP
- rs368862873
- Type
- single nucleotide variant
- Location
- chr16:88648078 (GRCh38)
- Gene constraint
- LOEUF 1.726 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.28 · 7 PDB
Disease context
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: chronic granulomatous disease
For Chronic granulomatous disease (Orphanet):
- Inheritance
- Autosomal recessive, X-linked recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CYBA p.Arg32Cys Uncertain significance ★★ ⚠ same residue
- CYBA p.Arg32Leu Uncertain significance ★ ⚠ same residue
- CYBA p.Arg32= Likely benign ★ same residue
- CYBA c.128+2T>C Likely pathogenic ★★ same condition
- CYBA c.204-2A>G Pathogenic/Likely pathogenic ★★ same condition
- CYBA c.287+1G>T Pathogenic/Likely pathogenic ★★ same condition
- CYBA c.287+2T>C Pathogenic/Likely pathogenic ★★ same condition
- CYBA c.288-1G>T Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cyba-p-arg32his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown